Dotmatics Appoints Mike McKee as the New President to Lead the Industry Transformation to Data-Driven Scientific Research
Highly-accomplished technology CEO to accelerate the Company’s immense scale and capitalize on unprecedented momentum
Bishop’s Stortford, UK, 21 September 2021: Dotmatics Ltd, an Insightful Science company that provides leading scientific informatics software to drive the automation of lab data workflows and accelerate critical R&D discovery, announced today the appointment of Mike McKee as its new President.
McKee is an experienced CEO with a demonstrated history of leadership in the technology industry. In his role, McKee will continue to accelerate the Company’s impressive growth, scale the high-performing global team with deep domain expertise, double R&D investments, and lead integration efforts with Insightful Science’s thriving portfolio of scientific research and data solutions serving more than 1.5 million global scientists.
McKee takes over the helm of Dotmatics from Founder, Stephen Gallagher, who will continue to focus on strategic growth initiatives involving investments, acquisitions, and product expansion opportunities across the Dotmatics and Insightful Science ecosystem.
Most recently, McKee was the Executive Vice President and General Manager of Insider Threat at Proofpoint (PFPT). Prior to this, McKee was the CEO of ObserveIT leading up to its purchase by Proofpoint for $225 million. During this tenure, he helped raise $40M in venture funding, tripled revenues, converted the company to a subscription model, and doubled the high-performing team headcount. Prior to ObserveIT, McKee led the award-winning Global Services and Customer Success organizations at Rapid7, a Bain Capital-backed security data and analytics company, that went public in July 2015.
McKee’s other positions further underpin his technology track-record and include Senior Vice President, CAD Operations & Strategy, at PTC, Inc., a software company, Chief Financial Officer at HighWired.com, an e-commerce solution provider, and Associate/Analyst roles at Broadview Associates, Ltd., McKinsey & Company and Goldman Sachs. He received a B.A. in economics and politics, cum laude, from Princeton University and a M.B.A., with honors, from Harvard Business School. McKee also played professional hockey for the Quebec Nordiques (now the Colorado Avalanche).
“I am extremely excited to join this very impressive company and team at the core of scientific innovation,” said Mike McKee, President of Dotmatics. “The impact of the transformation to data-driven scientific research that Dotmatics is spearheading cannot be understated — it will fuel the revolution of science that propels us to unimaginable new heights. I am honored to be a part of a company with the vision to make the world a healthier, cleaner, and better place to live.”
Dotmatics is a privately held portfolio company of Insight Partners, the leading global venture capital and private equity firm investing in high-growth technology and software ScaleUp companies.
“On behalf of Insight Partners and the Dotmatics Founders, Stephen Gallagher and Alastair Hill, I am thrilled to welcome Mike to the team,” said Thomas Swalla, CEO of Insightful Science. “He has proven critical skills in strategy, sales, customer success, operations and finance, and has a passion for building strong teams and an intense focus on driving customer value. We are beyond excited to have his leadership and experience to harness our current momentum and guide us into our next phase of growth.”
McKee is joining Dotmatics following a year of significant momentum. In March 2021, Dotmatics was acquired by Insightful Science. The combined Company, which previously announced it will generate well over $100 million of ARR, forms the only end-to-end platform with the world’s leading chemistry and biology solutions serving the broadest set of scientific domains.
Recently the Company also announced the appointment of Michael Swartz, the industry leader from PerkinElmer, as Senior Vice President Enterprise Product to lead enterprise product vision, strategy, and roadmap. Dotmatics will continue to expand its leadership to support rapid growth.
About Insightful Science
Insightful Science is a scientific software company that is enabling the Cloud for Scientific Discovery. From developing new personalized and preventive patient treatment solutions to reversing climate change — more than two million researchers at leading life science, biopharma and chemical and materials enterprises trust Insightful Science products to make the world a healthier, cleaner, and better place to live. Products within the Insightful Science portfolio were built by prominent scientists, and include GraphPad Prism, Geneious Prime and Geneious Biologics, Dotmatics, SnapGene, nQuery, Cytapex, and more.
Visit www.insightfulscience.com for more information about the Company and its products.
Dotmatics is a scientific informatics software and services company that is driving the automation of laboratory workflows for discovery and innovation research – accelerating the journey towards full digitalization and the Lab of the Future.
In April 2021, Dotmatics was acquired by Insightful Science and combined, are now the world’s largest cloud-based scientific research R&D platform.
With a mission to give scientists access to all of their data, all of the time, Dotmatics provides a unique portfolio of tools for fully automated, end-to-end workflows including data acquisition, knowledge management, data storage, enterprise querying and reporting, and data analytics and visualization. Through these comprehensive solutions, the Company is helping its customers to increase lab efficiency and make better informed decisions driven by all data.
Dotmatics’ customers include many of the world’s leading pharmaceutical, biotechnology, contract research, chemicals and materials companies. Insight into the challenges faced by these organizations enables Dotmatics to focus on delivering versatile and intuitive products and services that have potential to turn around the productivity deficit in research and accelerate development of novel drug candidates or products.
Dotmatics was founded in 2005 by two scientists from Merck Pharmaceuticals (MSD). Since then, it has built a strong and profitable business and in 2020 acquired BioBright, a Boston-based company automating secure data collection and analysis from laboratory and biomanufacturing environments.
T: +44 (0)7771 730 919